Results 111 to 120 of about 1,314 (191)

Fluocinolone Acetonide Intravitreal Implant 190 μg (ILUVIEN®) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema

Ophthalmic Research, 2017
Purpose: To compare the functional and anatomical outcomes after a 0.2 µg/day fluocinolone acetonide (FAc) implant between vitrectomized and nonvitrectomized eyes with chronic diabetic macular edema (DME).
B. Pessoa, J. Coelho, Nuno Correia, N. Ferreira, M. Beirão, A. Meireles   +5 more
semanticscholar   +1 more source

Fluocinolone acetonide 0.19 mg intravitreal implant improves foveal thickness and reduces treatment burden for up to 1 year in eyes with persistent diabetic macular edema

International Medical Case Reports Journal, 2019
Joseph M ConeyRetina Associates of Cleveland, Cleveland, OH, USAObjective: To assess the effectiveness, safety, and treatment burden in eyes with persistent diabetic macular edema (DME) for up to 1 year after administration of 0.19 mg fluocinolone ...
Coney JM
doaj  

Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant

Diabetes, Metabolic Syndrome and Obesity, 2015
Zafer Cebeci, Nur KirDepartment of Ophthalmology, Istanbul Faculty of Medicine, Istanbul University, Capa, Istanbul, TurkeyAbstract: Diabetic macular edema (DME) is the leading cause of sight-threatening complication in diabetic patients, and several ...
Cebeci Z, Kir N
doaj  

Uso de implante de acetónido de fluocinolona en edema macular diabético crónico o recidivante [PDF]

, 2023
[spa] Se evalúa la efectividad del implante intravítreo de 0.19 mg de FAc (Iluvien®, Alimera Sciences, Inc) en el tratamiento del edema macular diabético crónico o recidivante.
Marroquino Díaz, Marina
core  

Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy

Eye, 2017
PurposeLimited data are available on the efficacy of the 0.2 μg/day fluocinolone acetonide (FAc) implant in eyes with prior vitrectomy. Here, we present a collection of 26 vitrectomized eyes treated with the 0.2 μg/day FAc implant.MethodsRetrospective ...
A. Meireles, C. Goldsmith, I. El-Ghrably, A. Erginay, Maki Habib, B. Pessoa, J. Coelho, T. Patel, R. Tadayoni, P. Massin, J. Atorf, A. Augustin   +11 more
semanticscholar   +1 more source

Exploring the Efficacy and Safety of Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) in the Management of Irvine-Gass Syndrome: Insights from a Retrospective Case Series Analysis

Acta Scientific Ophthalmology, 2023
J. Ambrósio, Vítor Miranda, C. Aguiar, Raquel Soares, João Chibante Pedro, M. Ruão   +5 more
semanticscholar   +1 more source

ILUVIEN ^® Technology in the Treatment of center-involving Diabetic Macular edema: a Review of the Literature [PDF]

Therapeutic Delivery, 2018
Diabetic macular edema (DME) is one of the major causes of blindness, caused primarily by hyperglycemia and results from multiple pathological processes mostly secondary to increased levels of VEGF and other inflammatory cytokines. DME management includes control of systemic risk factors together with laser photocoagulation, frequent intraocular ...
openaire   +2 more sources

Fluocinolone Acetonide 0.19 mg Implant in Patients with Cystoid Macular Edema Due To Irvine–Gass Syndrome

International Medical Case Reports Journal, 2021
João Heitor Marques,1 Ana Carolina Abreu,1 Nisa Silva,1 Angelina Meireles,1,2 Bernardete Pessoa,1,2 João Melo Beirão1,2 1Serviço de Oftalmologia, Centro Hospitalar e Universitário do Porto, Porto, Portugal; 2Instituto ...
Marques JH, Abreu AC, Silva N, Meireles A, Pessoa B, Melo Beirão J   +5 more
doaj  

[Comparison of available clinical and imaging tools to assess good positioning of a fluocinolone acetonide implant (Iluvien®) in the vitreous cavity after injection].

Journal Francais d'Ophtalmologie, 2023
E. Jomaa, S. Koudsié, B. Gontier, M. Rougier, S. Gattoussi, P-H Seguy, M. Azar, J. Korobelnik, M. Delyfer   +8 more
semanticscholar   +1 more source

Novel Intraocular Therapy in Non-infectious Uveitis of the Posterior Segment of the Eye [PDF]

, 2013
This article reviews the new clinically relevant data regarding the intraocular treatment of non-infectious uveitis. Triamcinolone acetonide is the most commonly used intravitreal corticosteroid for treatment of uveitis and uveitic macular oedema.
Mikhail, Michael, Sallam, Ahmed
core   +1 more source